Title
Category
Credits
Event date
Cost
Cancer Pathology: How Diagnosis Drives Treatment
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
Where the Rubber Meets the Road: Community-Inclusive Interventions to Achieve Equity in Cancer Care - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Samuel Cykert, MD, and Christina Yongue, MPH, MCHES, describe the long-lasting racial disparities in breast and lung cancer care, and some of the root causes for these inequities. Participants will learn how a community-academic-medical partnership addressed these disparities by designing system-change interventions based on antiracism principles.
Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
Multidisciplinary/Multimodality Management of Locally Recurrent Rectal Cancer - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 Participation
$0.00
Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.
Clinical Updates in Breast Oncology - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.
Update on Prostate Cancer Screening
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
Genitourinary Cancer Management in North Carolina
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.25 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
Sarcoma Management in North Carolina: Updates for 2023
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Mark Woodcock gives a broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
Lymphoma Management in North Carolina: Updates for 2023
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.

Pages